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Introduction: The Medial Temporal-lobe Atrophy index (MTAi), 2D-Medial Temporal
Atrophy (2D-MTA), yearly rate of MTA (yrRMTA) and yearly rate of relative MTA (yrRMTA)
are simple protocols for measuring the relative extent of atrophy in the medial temporal
lobe (MTL) in relation to the global brain atrophy. Albeit preliminary studies showed
interest of these methods in the diagnosis of Alzheimer’s disease (AD), frontotemporal
lobe degeneration (FTLD) and correlation with cognitive impairment in Parkinson’s disease
(PD), formal feasibility and validity studies remained pending. As a first step, we aimed
to assess the feasibility. Mainly, we aimed to assess the reproducibility of measuring the
areas needed to compute these indices. We also aimed to assess the efforts needed to
start using these methods correctly.
Methods: A series of 290 1.5T-MRI studies from 230 subjects ranging 65–85 years old
who had been studied for cognitive impairment were used in this study. Six inexperienced
tracers (IT) plus one experienced tracer (ET) traced the three areas needed to compute
the indices. Finally, tracers underwent a short survey on their experience learning to
compute the MTAi and experience of usage, including items relative to training time
needed to understand and apply the MTAi, time to perform a study after training and overall
satisfaction.
Results: Learning to trace the areas needed to compute the MTAi and derived methods
is quick and easy. Results indicate very good intrarater Intraclass Correlation Coefficient
(ICC) for the MTAi, good intrarater ICC for the 2D-MTA, yrMTA and yrRMTA and also good
interrater ICC for the MTAi, 2D-MTA, yrMTA and yrRMTA.
Conclusion: Our data support that MTAi and derived methods (2D-MTA, yrMTA and
yrRTMA) have good to very good intrarater and interrater reproducibility and may be easily
implemented in clinical practice even if new users have no experience tracing the area of
regions of interest.
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INTRODUCTION
The recent focus on biomarkers in the diagnosis of Alzheimer’s
disease (AD) have created a need to translate research findings
into tools for use in everyday clinical practice. Although AD
and mild cognitive impairment (MCI) are commonly diagnosed
using criteria based in clinical findings, MRI findings may aid
the clinical diagnosis, and may predict clinical progression. New
research criteria have recently been proposed for AD, and MCI
that incorporate (disproportionate) medial temporal lobe (MTL)
or hippocampal atrophy on MRI as one of the supportive features.
Age-associated differences are detected in the MTL with an
acceleration of Medial Temporal Lobe Atrophy (MTA) starting
around 72 years of age in healthy people (Jack et al., 2004; Salk
et al., 2014). However, these changes are modest and their rate
of progression over time is relatively slow with a mean rate of
about 1.6% per year. Accelerated MTA is a consistent finding
in AD and MCI with rates of about 2.8% in stable MCI, 3.7%
in MCI transitioning to AD (MCI progressors), and up to
4.0% in AD. Frontotemporal dementia may also lead to MTA,
but in a different pattern: behavioral frontotemporal dementia
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and semantic dementia show atrophy in the anterior portion
of the hippocampus, and in semantic dementia the atrophy is
asymmetrical, with the left hippocampus being affected more
severely. No significant hippocampal atrophy is detected in
non-fluent progressive aphasia (Mesulam et al., 2014). Other
diseases such as dementia with Lewy bodies do not show MTA or
it is much milder (Menéndez-González et al., 2014).
All these changes can be measured on brain MRI using differ-
ent approaches on structural MRI. Volumetric techniques quan-
tify the volume of regions of interest on ad-hoc MRI studies that
are quantified by using well manual well automatic image analysis.
Planimetry methods are conceived to be used on standard MRI
studies in routine clinical practice by measuring the area of
regions of interest manually. Linear methods use measures of
the width or height of brain structures, including the ventricular
system or spaces around the brain cortex. Visual assessment rating
scales are a quick way of assessing atrophy of the MTL on one
single coronal MRI slice straightforward, and can be performed
easily in the clinical setting; the disadvantage is that these scales
are totally subjective and there is a loss of accuracy compared with
objective analysis (Scheltens et al., 1992).
In contrast to MTA, ventricular enlargement in old people
lacks specificity, representing a measure of global brain atrophy
and is strongly associated with aging both in healthy and diseased
people. In addition, almost any neurodegenerative disorder affect-
ing the brain hemispheres leads to some degree of ventricular
enlargement, and so do some psychiatric conditions. Thus, it is
interesting to compare measures indicative of atrophy in the MTL
with measures indicative of global brain atrophy. This can be done
using volumetry (3D) or planimetry (2D).
Shortly, the “Medial Temporal-lobe Atrophy index” (MTAi),
is a simple method for measuring the relative extent of atrophy
in the MTL in relation to the global brain atrophy (Menéndez-
González, 2014b). This 2D-method consists on calculating a ratio
using the area of three regions traced manually on one single
coronal MRI slide. High values are suggestive of atrophy in the
MTL out of proportion to other brain structures, and therefore
the pattern of atrophy matches the expected in typical AD (Galton
et al., 2001; van de Pol et al., 2006).
Albeit preliminary studies showed interest of planimetric
methods for diagnosing AD, frontotemporal lobe degeneration
(FTLD) and cognitive impairment in Parkinson’s disease (PD)1,
formal feasibility and validity studies remained pending. As a first
step, we aimed to assess the feasibility of the MTAi and derived
methods: 2D-Medial Temporal Atrophy (2D-MTA), yearly rate
of MTA (yrRMTA) and tyearly rate of relative MTA (yrRMTA).
Mainly, we aimed to assess the reproducibility of measuring the
areas needed to compute these indices. Reproducibility refers to
the degree of agreement between measurements or observations
conducted on replicate specimens by different people, as part of
the precision of a test method. Test–retest variability can be caused
by intra-individual variability and intra-observer variability.
These parameters have paramount importance when validating
a new diagnostic test (Bossuyt et al., 2003); and some recommen-
dations on the validation of biomarkers for diagnosing dementias
1http://brainatrophyindices.blogspot.com
have also remarked the importance of assessing them in first term
(McGhee et al., 2014; Noel-Storr et al., 2014). We also aimed to
assess the efforts needed to start using these methods correctly.
METHODS
A series of 230 1.5T-MRI studies of subjects ranging 65–85 years
old who had been studied for cognitive impairment were used
in this study. Six inexperienced tracers (IT) plus one experienced
tracer (ET) took part in this study. IT had different backgrounds
in life sciences, basic neuroanatomical knowledge, and no pre-
vious experience in tracing areas of brain regions at all. The ET
is one of the researchers who described the methods and has
extensive experience using them.
First, the IT read the protocol of the MTAi (Menéndez-
González, 2014a). They were in charge of installing the DICOM
software, loading MRI studies, selecting the appropriate slide and
tracing the three areas needed to compute the MTAi on each
hemisphere (right and left A, B and C) according to the original
protocol, on a number of MRI studies ranging from 20 to 120
cases. The IT used different DICOM viewers depending on the
operating system installed in their computers: 3 IOS users used
Osirix™ and 3 Windows users used ONIS™. The areas traced
by the IT were corrected by the ET in all cases. The MTAi
consists on calculating a ratio using the area of three regions
traced manually on one single coronal MRI slide at the level of
the interpeduncular fossa: (1) the MTL region (A), defined in a
coronal brain slide as the four-sided space bordered in its inferior
side by the tentorium cerebelli, in its medial side by the cerebral
peduncles, in its upper side by the roof of the temporal horn
of the lateral ventricle and in its lateral side by the collateral
sulcus and a straight-line linking the collateral sulcus with the
lateral edge of the temporal horn of the lateral ventricle; (2) the
parenchima within the medial temporal region, that includes
the hippocampus and the parahippocampal gyrus—the fimbria
taenia and plexus choroideus are excluded—(B); and (3) the body
of the ipsilateral lateral ventricle (C) (Figure 1). Therefrom we
can compute the “2D-Medial Temporal Atrophy” (2D-MTA =
A−B) that represents absolute atrophy of the MTL; and the ratio
“Medial Temporal Atrophy index” (MTAi = (A−B) × 10/C) that
represents the relative atrophy of the MTL in comparison with
the enlargement of the lateral ventricles, that represent global
brain atrophy. The MTAi is suitable to assess the asymmetry of
relative MTA within a subject. High asymmetry is typical of some
types of FTLD. However, as there is important inter-individual
variability in the size of the lateral ventricles, this index is not
recommended for comparing subjects but to track the progression
in a given subject over time. Indeed, if we have 2 MRI studies
from different times (1 = first one, 2 = second one), we can also
compute the yrMTA as follows: yrMTA = (A2−B2)−(A1−B1) ×
1200/(#months between MRI studies) and the yearly rate of rela-
tive MTA (yrRMTA) as follows: yrRMTA=(A2−B2)−(A1−B1) ×
1200/(C2−C1)× (# months between MRI studies).
Finally, tracers underwent a short survey on their experience
learning to compute the MTAi and experience of usage, including
items relative to training time needed to understand and apply
the MTAi (number of attempts needed until the ET verified the
tracing was correct), time needed to perform a study after training
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FIGURE 1 | MRI coronal section passing through the interpeduncular
fosae. The boundaries of the three areas needed for calculating the Medial
Temporal Atrophy index (MTAi) and derived methods have been drawn in
three different colors: (1) the medial temporal lobe region (A, red), defined
in a coronal brain slide as the space bordered in its inferior side by the
tentorium cerebelli, in its medial side by the cerebral peduncles, in its upper
side by the roof of the temporal horn of the lateral ventricle and in its lateral
side by the colateral sulcus and a straight-line linking the colateral sulcus
with the lateral edge of the temporal horn of the lateral ventricle; (2) the
parenchima within the medial temporal region, that includes the
hippocampus and the parahippocampal girus (B, blue); and (3) the body of
the ipsilateral lateral ventricle (C, green).
(timed by the own tracers, in minutes) and overall satisfaction
(measured using a simple qualitative scale: easy/normal/hard).
Statistical analyses were performed with the softwares R™and
Epidat™. Computation of the MTA, 2D-MTA, yrMTA and
yrRMTA were made following the formulas explained above
(Menéndez-González et al., 2014). The reproducibility was
assessed using the Intraclass Correlation Coefficient (ICC)-
Model 2, one by one for every of the three areas needed to
compute the MTAi on each hemisphere and for the final MTAi
results (right and left). We used a qualitative scale to qualify the
strength of concordance as very good (>0.90), good (0.80–0.90),
moderate (0.60–0.80) and poor (<0.60).
RESULTS
REPRODUCIBILITY: RESULTS FROM THE TEST-RETEST STUDIES
In total, IT traced areas from 290 MRI studies from 230 cases,
60 of which also had a 1-year follow-up MRI study. Ninety
studies were traced twice by the same IT (180 sets of results),
and 200 were traced twice by 2 different IT (400 sets of results).
We used the set of 180 double-traced by same-tracer results to
assess the intrarater reproducibility and the set of 400 double-
traced by different-tracer results to assess the interrater repro-
ducibility. Thirty cases of the each set corresponded to the 1 year
follow-up MRI. Thus, we computed the yrMTA and the yrRMTA
in 60 cases and the MTAi and 2D-MTA in 230 cases. Results of
intrarater and interrater reproducibility are shown in Tables 1, 2
respectively.
SATISFACTION: RESULTS FROM THE SURVEY
IT needed to train with 2–5 cases (mean 3 cases) before being able
to compute the MTAi on their own correctly. After training, IT
needed between 4 and 7 min (mean 5 min) to examine a new case.
All tracers rated the method as “easy to learn” and “easy to apply”.
DISCUSSION
One of the strengths of planimetry methods is that can be
measured using almost any of the DICOM softwares commonly
used by clinicians or radiologists to visualize medical images
worldwide. Most of these softwares are intuitive and require
little or no training at all. Learning to trace the areas needed to
compute the MTAi and derived methods is quick and easy even
for naive tracers. Even more importantly, tracing these areas have
good intra- and interrater reproducibility. As expected, the area
with the best intra- and interrater ICC was area C—the lateral
ventricle—since it has the easiest anatomical limits. Areas A and
B had poorer intrarater and interrater ICC since anatomical
limits are somewhat more complicated. However, the intrarater
and interrater ICC for areas A and B is still good enough to
yield very good intrarater ICC for the MTAi, good intrarater ICC
for the 2D-MTA, yrMTA and yrRMTA and also good interrater
ICC for the MTAi, 2D-MTA, yrMTA and yrRMTA. These results
are comparable to those from automatic volumetry (Hsu et al.,
2002; Wolz et al., 2014) and much better than those from manual
volumetry and visual scales (Scheltens et al., 1997; Hsu et al.,
2002). Particularly, assessment of cerebral atrophy using visual
rating scales is totally subjective and has moderate intrarater and
poor interrater reproducibility (Scheltens et al., 1997).
Table 1 | Intrarater Intraclass Correlation Coefficient and strength of
concordance among the different areas needed to compute the MTAi,
2D-MTA, yrMTA and yrRMTA.
CCI CI 95% Strength
Mean Inferior Superior
rA 0.87 0.68 0.91 Good
lA 0.86 0.66 0.90 Good
rB 0.83 0.71 0.89 Good
lB 0.84 0.76 0.87 Good
rC 0.95 0.92 0.94 Very good
lC 0.94 0.91 0.96 Very good
rMTAi 0.91 0.90 0.92 Very good
lMTAi 0.92 0.91 0.93 Very good
r2D-MTA 0.88 0.80 0.95 Good
l2D-MTA 0.85 0.81 0.89 Good
ryrMTA 0.82 0.76 0.89 Good
lyrMTA 0.84 0.77 0.90 Good
ryrRMTA 0.81 0.77 0.87 Good
lyrRMTA 0.83 0.75 0.89 Good
r: right hemisphere; l: left hemisphere.
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Table 2 | Interrater Intraclass Correlation Coefficient and strength of
concordance among the different areas needed to compute the MTAi,
2D-MTA, yrMTA and yrRMTA.
CCI CI 95% Strength
Mean Inferior Superior
rA 0.87 0.69 0.92 Good
lA 0.86 0.72 0.91 Good
rB 0.83 0.69 0.89 Good
lB 0.84 0.71 0.89 Good
rC 0.88 0.73 0.91 Very good
lC 0.90 0.87 0.92 Very good
rMTAi 0.88 0.82 0.92 Good
lMTAi 0.87 0.83 0.91 Good
r2D-MTA 0.84 0.79 0.90 Good
l2D-MTA 0.85 0.81 0.91 Good
ryrMTA 0.83 0.74 0.89 Good
lyrMTA 0.83 0.75 0.90 Good
ryrRMTA 0.82 0.75 0.88 Good
lyrRMTA 0.81 0.76 0.86 Good
r: right hemisphere; l: left hemisphere.
Accurate manual volumetric assessment requires standard
operating procedures that include the know-how specific for
the modality, acquisition parameters, and extensive learning
and ad-hoc softwares that also require training to be used
correctly (Frisoni et al., 2014). In addition, harmonization of
manually segmented hippocampus is still in progress (Frisoni
and Jack, 2011). Thus, manual volumetric methods have a steep
learning curve while the MTAi while derived 2D methods have
a learning curve with a quick start. The MTAi and derived
methods may be easily implemented for estimating MTA in
clinical practice, even if new users have no experience tracing the
area of regions of interest. Indeed, any health professional with
basic neuroanatomical knowledge can take these measures after
short training. The MTAi and derived methods can also readily
be incorporated into a standardized radiological report and may
also be useful in clinical trials.
CONCLUSIONS
In conclusion, results from this feasibility study support that the
MTAi and derived methods (2D-MTA, yrMTA and yrRMTA)
have good to very good intrarater and interrater reproducibility
and may be easily implemented for estimating MTA in clinical
practice, even if new users have no experience tracing the area of
regions of interest.
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